MXCT

MaxCyte, Inc. NASDAQ Listed Jul 30, 2021

Healthcare ·Medical - Devices ·US · maxcyte.com

$0.87

Mkt Cap $93.1M

52w Low $0.64 10.9% of range 52w High $2.74

50d MA $0.80 200d MA $1.30

P/E (TTM) -2.1x

EV/EBITDA -4.2x

P/B 0.6x

Debt/Equity 0.1x

ROE -26.0%

P/FCF -4.6x

RSI (14) —

ATR (14) —

Beta 1.45

50d MA $0.80

200d MA $1.30

Avg Volume 1.1M

MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company was incorporated in 1998 and is headquartered in Rockville, Maryland.

SIC Code

8731

CIK (SEC)

1287098

Phone

301 944 1700

9713 Key West Avenue · Rockville, MD 20850 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Mar 24, 2026	AMC	-0.08	-0.06	+25.0%	0.74	-1.4%	-6.8%	+3.9%	-4.6%	-1.1%	+3.9%	—
Nov 12, 2025	AMC	-0.11	-0.12	-9.1%	1.58	-3.8%	-4.4%	+4.6%	+3.2%	+4.9%	-0.6%	—
Aug 6, 2025	AMC	-0.10	-0.12	-20.0%	2.04	-16.7%	-29.9%	-3.5%	-4.3%	-3.8%	+8.7%	—
May 7, 2025	AMC	-0.10	-0.10	+0.0%	2.74	-10.6%	-11.3%	-2.9%	-3.8%	-3.1%	+0.0%	—
Mar 11, 2025	AMC	-0.12	-0.10	+16.7%	3.47	-10.4%	-8.4%	-3.8%	+7.5%	-0.9%	-2.1%	—
Nov 6, 2024	AMC	-0.13	-0.11	+15.4%	3.88	+3.4%	-10.8%	-2.0%	+5.6%	-1.1%	+0.3%	—
Aug 6, 2024	AMC	-0.14	-0.09	+35.7%	4.45	+4.0%	-8.3%	+2.5%	+0.0%	-3.6%	+0.2%	—
May 7, 2024	AMC	-0.14	-0.09	+35.7%	3.93	+0.3%	+18.1%	+1.9%	+0.2%	-0.6%	-3.6%	—
Mar 12, 2024	AMC	-0.10	-0.05	+50.0%	3.98	+1.8%	+4.5%	+1.0%	+2.6%	-3.2%	+7.0%	—
Nov 8, 2023	AMC	-0.10	-0.11	-10.0%	3.35	-3.0%	-3.3%	+1.5%	+5.8%	+6.6%	+0.8%	—
Aug 9, 2023	AMC	-0.10	-0.10	+0.0%	4.36	-7.3%	-10.3%	-1.8%	+0.0%	-0.8%	-4.2%	—
May 10, 2023	AMC	-0.11	-0.11	+0.0%	4.65	-12.5%	-19.8%	+2.7%	-1.3%	-2.4%	+3.3%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Mar 25	Craig-Hallum	Maintains	Buy → Buy	—	$0.74	$0.73	-1.4%	-6.8%	+3.9%	-4.6%	-1.1%	+3.9%
Aug 11	BTIG	Downgrade	Buy → Neutral	—	$1.38	$1.36	-1.4%	-4.3%	-3.8%	+8.7%	+2.2%	-3.5%
Aug 7	William Blair	Downgrade	Outperform → Market Perform	—	$2.04	$1.70	-16.7%	-29.9%	-3.5%	-4.3%	-3.8%	+8.7%
Mar 12	Stifel	Maintains	Buy → Buy	—	$3.47	$3.11	-10.4%	-8.4%	-3.8%	+7.5%	-0.9%	-2.1%
Apr 23	Stephens & Co.	Maintains	Overweight → Overweight	—	$3.96	$3.97	+0.3%	-4.0%	-1.6%	-1.3%	+0.5%	-1.3%
Mar 13	BTIG	Maintains	Buy → Buy	—	$3.98	$4.05	+1.8%	+4.5%	+1.0%	+2.6%	-3.2%	+7.0%
Mar 13	Stephens & Co.	Maintains	Overweight → Overweight	—	$3.98	$4.05	+1.8%	+4.5%	+1.0%	+2.6%	-3.2%	+7.0%
Oct 5	Stephens & Co.	Maintains	Overweight → Overweight	—	$3.27	$2.53	-22.6%	-20.5%	+10.0%	+5.2%	+1.7%	-2.3%
Mar 28	Stephens & Co.	Maintains	Overweight → Overweight	—	$4.11	$4.12	+0.2%	-0.7%	+8.1%	+6.6%	+5.3%	-3.2%
Aug 15	BTIG	Maintains	Buy → Buy	—	$5.87	$5.85	-0.3%	-2.0%	+7.3%	-2.8%	-0.7%	-5.7%
Aug 24	BTIG	Maintains	Buy → Buy	—	$14.34	$14.40	+0.4%	-2.6%	-2.2%	+2.9%	+12.4%	-3.0%
Aug 24	Cowen & Co.	Maintains	Outperform → Outperform	—	$14.34	$14.40	+0.4%	-2.6%	-2.2%	+2.9%	+12.4%	-3.0%
Aug 24	Stephens & Co.	Maintains	Overweight → Overweight	—	$14.34	$14.40	+0.4%	-2.6%	-2.2%	+2.9%	+12.4%	-3.0%
Aug 24	Stifel	Maintains	Buy → Buy	—	$14.34	$14.40	+0.4%	-2.6%	-2.2%	+2.9%	+12.4%	-3.0%
Aug 24	William Blair	Maintains	Outperform → Outperform	—	$14.34	$14.40	+0.4%	-2.6%	-2.2%	+2.9%	+12.4%	-3.0%

Data updated apr 26, 2026 1:59pm · Source: massive.com